These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 302996)

  • 21. Hemophilia in Sweden. Studies on demography of hemophilia and surgery in hemophilia and von Willebrand's disease.
    Larsson SA
    Acta Med Scand Suppl; 1984; 684():1-72. PubMed ID: 6611018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS surveillance in haemophilia.
    Daly HM; Palmer R; Scott GL; Lee G
    Br J Haematol; 1985 Feb; 59(2):383-90. PubMed ID: 3918559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Herpes and HIV infection in hemophilic subjects].
    Musso A; Riva C; Valpreda A; Perugini L; Negro F; Migliore G
    Minerva Pediatr; 1988 Nov; 40(11):621-4. PubMed ID: 2854606
    [No Abstract]   [Full Text] [Related]  

  • 24. Recommendations on choice of therapeutic products for the treatment of patients with haemophilia A, haemophilia B and von Willebrand's disease. UK Regional Haemophilia Centre Directors Committee.
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):205-14. PubMed ID: 1606293
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleeding and clotting: new therapies and old issues revisited.
    Lee CA; Aledort LM
    Haemophilia; 2009 Mar; 15(2):592-6. PubMed ID: 19335754
    [No Abstract]   [Full Text] [Related]  

  • 27. [Physiopathology and therapy of hemophilia and von Willebrand's disease].
    Fukui H
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):866-74. PubMed ID: 1919201
    [No Abstract]   [Full Text] [Related]  

  • 28. Medical staff conference: Hemophilia and von Willebrand's disease. Fourth annual Paul M. Aggeler memorial lecture.
    West J Med; 1974 Mar; 120(3):226-32. PubMed ID: 4544608
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunization of haemophiliacs against hepatitis B. A joint study between the haemophilia centers in Leuven, Belgium and Malmö, Sweden.
    Hedner U; Hansson BG; Vermylen J; Verstraete M; Colaert J; Desmyter J
    Scand J Haematol Suppl; 1984; 40():317-21. PubMed ID: 6236549
    [No Abstract]   [Full Text] [Related]  

  • 30. Frequency and clinical and transfusional significance of rheumatoid factor in patients with haemophilia and von Willebrand's disease.
    Celada A; Aguado MT; Ortega F; Magallon M; Martin-Villar J; Lambert PH
    Vox Sang; 1984; 47(4):271-5. PubMed ID: 6333107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of HBV vaccine in hemophiliacs.
    Gazengel C; Courouce AM; Torchet MF; Kremp O; Brangier J; Brechot C; Degos F
    Scand J Haematol Suppl; 1984; 40():323-8. PubMed ID: 6236550
    [No Abstract]   [Full Text] [Related]  

  • 32. [Incidence of hepatitis B in hemophilia patients].
    Thoms J; Berles R; Syrbe G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):523-9. PubMed ID: 2446993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver dysfunction in Pennsylvania's multitransfused hemophiliacs.
    Hasiba U; Eyster ME; Gill FM; Kajani M; Lewis JH; Lusch CJ; Prager D; Rice SA; Shapiro SS
    Dig Dis Sci; 1980 Oct; 25(10):776-82. PubMed ID: 6775916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications After TKA in Patients With Hemophilia or Von Willebrand's Disease.
    Cancienne JM; Werner BC; Browne JA
    J Arthroplasty; 2015 Dec; 30(12):2285-9. PubMed ID: 26143236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis in haemophilia (author's transl)].
    Stampfli K
    Ther Umsch; 1979 Apr; 36(4):322-5. PubMed ID: 377555
    [No Abstract]   [Full Text] [Related]  

  • 36. Baseline seroepidemiology of hepatitis B virus infection in two Saudi high-risk groups: patients on haemodialysis and patients with congenital bleeding disorders.
    Arif M; al-Momen AK; Huraib S; Ramia S
    Trans R Soc Trop Med Hyg; 1989; 83(2):256-7. PubMed ID: 2609380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonprogressive course of non-A, non-B chronic hepatitis in multitransfused hemophiliacs.
    Mannucci PM; Colombo M; Rizzetto M
    Blood; 1982 Sep; 60(3):655-8. PubMed ID: 6809075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease.
    Kim HC; Saidi P; Ackley AM; Bringelsen KA; Gocke DJ
    Gastroenterology; 1980 Dec; 79(6):1159-64. PubMed ID: 6777232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools.
    Rollag H; Evesen SA; Fröland SS; Glomstein A
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):612-4. PubMed ID: 2170135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.